Cornell prime dots | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,975 results for “Cornell prime dots”

Trials

View all 3653 →

A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding

200,000 participants · First posted Dec 22, 2006

A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis

6,400 participants · First posted Apr 24, 2006

Cost-effectiveness of Two Forms of DOTS in a Demonstration Area of the DOTS Strategy in Colombia

264 participants · First posted Sep 19, 2013

Drugs

View all 297 →

AAV2CUhCLN2(Cornell University)

betulinol derivatives (Cornell/Marc Pharmaceuticals)

Grafix

Organizations

View all 54 →

PRIME MEDICINE

India

CORNELL UNIVERSITY

United States

Cornell College

United States

News

View all 971 →

Cornell-Developed Silica Nanoparticles Transform Cold Tumors to Enhance Immunotherapy Response

Engineered Silica Nanoparticles Eradicate Aggressive Prostate Cancer in Mice by Triggering Ferroptosis and Immune Activation

Scientific Industries Launches DOTS MPS for Cell Culture Biopharma Market, Reports 24% Bioprocessing Revenue Growth

Page 1 of 498